Home » Stocks » SDGR

Schrodinger, Inc. (SDGR)

Stock Price: $48.78 USD -3.31 (-6.35%)
Updated Oct 30, 2020 4:00 PM EDT - Market closed
After-hours: $48.81 +0.03 (0.06%) Oct 30, 7:59 PM

Stock Price Chart

Key Info

Market Cap 3.34B
Revenue (ttm) 95.06M
Net Income (ttm) -35.45M
Shares Out 55.40M
EPS (ttm) -0.80
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 30, 2020
Last Price $48.78
Previous Close $52.09
Change ($) -3.31
Change (%) -6.35%
Day's Open 51.70
Day's Range 47.59 - 51.74
Day's Volume 1,470,650
52-Week Range 25.50 - 99.50

More Stats

Market Cap 3.34B
Enterprise Value 3.07B
Earnings Date (est) Nov 12, 2020
Ex-Dividend Date n/a
Shares Outstanding 55.40M
Float 52.55M
EPS (basic) -0.80
EPS (diluted) -0.80
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 5.12M
Short Ratio 2.94
Short % of Float 9.75%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 35.18
PB Ratio 13.64
Revenue 95.06M
Operating Income -48.03M
Net Income -35.45M
Free Cash Flow n/a
Net Cash 270.91M
Net Cash / Share 3.95
Gross Margin 51.65%
Operating Margin -50.52%
Profit Margin -37.30%
FCF Margin n/a
ROA -11.63%
ROE -18.21%
ROIC -24.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (4)

Buy 2
Overweight 0
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

(78.86% upside)
Current: $48.78
Target: 87.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth28.37%19.65%-
Gross Profit49.0942.9439.80
Operating Income-38.72-27.97-19.02
Net Income-24.57-28.43-17.39
Shares Outstanding44.8943.1434.45
Earnings Per Share-0.55-0.66-0.50
Operating Cash Flow-26.06-23.71-15.31
Capital Expenditures-1.84-5.26-3.70
Free Cash Flow-27.90-28.97-19.01
Cash & Equivalents86.3384.0736.34
Total Debt14.47--
Net Cash / Debt71.8684.0736.34
Book Value-93.36-71.56-45.36
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Schrodinger, Inc.
Country United States
Employees 392
CEO Ramy Farid

Stock Information

Ticker Symbol SDGR
Stock Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Unique Identifier NASDAQ: SDGR
IPO Date February 6, 2020


Schrödinger provides computational platform to accelerate drug discovery and materials design for biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. The company operates through two segments, Software and Drug Discovery. It segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment develops a pipeline of preclinical and clinical drug discovery programs through its computational platform in collaboration with pharmaceutical companies. Schrödinger, Inc. has strategic collaborations with Twist Bioscience Corporation; and Thermo Fisher Scientific to extend the use of cryo-EM in connection with in silico compound screening to accelerate drug discovery. The company was founded in 1990 and is based in New York.